Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1910 1
1941 1
1961 1
1963 1
1966 1
1969 1
1970 2
1971 2
1972 2
1974 1
1979 1
1981 2
1982 2
1983 5
1984 4
1985 2
1987 1
1988 1
1989 1
1990 3
1991 3
1992 1
1993 3
1994 4
1995 4
1996 3
1997 7
1998 10
1999 5
2000 3
2001 2
2002 4
2003 5
2004 2
2005 2
2006 2
2007 1
2008 4
2009 1
2010 2
2011 7
2012 4
2013 4
2014 5
2015 1
2016 6
2017 4
2018 4
2020 4
2021 6
2022 3
2023 5
2024 7
2025 7
2026 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

165 results

Results by year

Filters applied: . Clear all
Page 1
Roflumilast Cream, 0.15%, for Atopic Dermatitis in Adults and Children: INTEGUMENT-1 and INTEGUMENT-2 Randomized Clinical Trials.
Simpson EL, Eichenfield LF, Alonso-Llamazares J, Draelos ZD, Ferris LK, Forman SB, Gooderham M, Gonzalez ME, Hebert AA, Kircik LH, Lomaga M, Moore A, Papp KA, Prajapati VH, Hanna D, Snyder S, Krupa D, Burnett P, Almaraz E, Higham RC, Chu DH, Berk DR. Simpson EL, et al. Among authors: burnett p. JAMA Dermatol. 2024 Nov 1;160(11):1161-1170. doi: 10.1001/jamadermatol.2024.3121. JAMA Dermatol. 2024. PMID: 39292443 Free PMC article. Clinical Trial.
Tape-strip profiling identifies unique immune and lipid dysregulation in patients with seborrheic dermatitis.
Ungar B, Manson M, Kim M, Gour D, Temboonnark P, Metukuru R, Correa Da Rosa J, Estrada Y, Gay-Mimbrera J, Gómez-Arias PJ, Ruano J, Shemer A, Hanna D, Burnett P, Guttman-Yassky E. Ungar B, et al. Among authors: burnett p. J Am Acad Dermatol. 2025 Jun;92(6):1277-1287. doi: 10.1016/j.jaad.2025.01.082. Epub 2025 Feb 1. J Am Acad Dermatol. 2025. PMID: 39900186 Free article.
Efficacy and Safety of Once-Daily Roflumilast Cream 0.05% in Pediatric Patients Aged 2-5 Years With Mild-to-Moderate Atopic Dermatitis (INTEGUMENT-PED): A Phase 3 Randomized Controlled Trial.
Eichenfield LF, Serrao R, Prajapati VH, Browning JC, Swanson L, Funk T, Gonzalez ME, Hebert AA, Lee M, Boguniewicz M, Simpson EL, Seal MS, Krupa D, Hanna D, Snyder S, Burnett P, Chu DH, Almaraz E, Higham RC, Berk DR. Eichenfield LF, et al. Among authors: burnett p. Pediatr Dermatol. 2025 Mar-Apr;42(2):296-304. doi: 10.1111/pde.15840. Epub 2025 Feb 20. Pediatr Dermatol. 2025. PMID: 39980188 Free PMC article. Clinical Trial.
Athlete's Foot.
Burnett P. Burnett P. Can Med Assoc J. 1941 Feb;44(2):198. Can Med Assoc J. 1941. PMID: 20322018 Free PMC article. No abstract available.
Roflumilast Foam, 0.3%, for Psoriasis of the Scalp and Body: The ARRECTOR Phase 3 Randomized Clinical Trial.
Gooderham MJ, Alonso-Llamazares J, Bagel J, Bhatia N, Bukhalo M, DuBois J, Ferris LK, Green L, Kircik LH, Lockshin B, Loo WJ, Papp KA, Soung J, Seal MS, Snyder S, Kato S, Krupa D, Burnett P, Berk DR, Chu DH. Gooderham MJ, et al. Among authors: burnett p. JAMA Dermatol. 2025 Jul 1;161(7):698-706. doi: 10.1001/jamadermatol.2025.1136. JAMA Dermatol. 2025. PMID: 40332898 Free PMC article. Clinical Trial.
Effect of Roflumilast Cream vs Vehicle Cream on Chronic Plaque Psoriasis: The DERMIS-1 and DERMIS-2 Randomized Clinical Trials.
Lebwohl MG, Kircik LH, Moore AY, Stein Gold L, Draelos ZD, Gooderham MJ, Papp KA, Bagel J, Bhatia N, Del Rosso JQ, Ferris LK, Green LJ, Hebert AA, Jones T, Kempers SE, Pariser DM, Yamauchi PS, Zirwas M, Albrecht L, Devani AR, Lomaga M, Feng A, Snyder S, Burnett P, Higham RC, Berk DR. Lebwohl MG, et al. Among authors: burnett p. JAMA. 2022 Sep 20;328(11):1073-1084. doi: 10.1001/jama.2022.15632. JAMA. 2022. PMID: 36125472 Free PMC article.
Roflumilast foam 0.3% for adolescent and adult patients with seborrheic dermatitis: A randomized, double-blinded, vehicle-controlled, phase 3 trial.
Blauvelt A, Draelos ZD, Stein Gold L, Alonso-Llamazares J, Bhatia N, DuBois J, Forman SB, Gooderham M, Green L, Guenthner ST, Hebert AA, Lain E, Moore AY, Papp KA, Zirwas M, Kato S, Snyder S, Krupa D, Burnett P, Berk DR, Chu DH. Blauvelt A, et al. Among authors: burnett p. J Am Acad Dermatol. 2024 May;90(5):986-993. doi: 10.1016/j.jaad.2023.12.065. Epub 2024 Jan 20. J Am Acad Dermatol. 2024. PMID: 38253129 Free article. Clinical Trial.
Erythema elevatum diutinum.
Burnett PE, Burgin S. Burnett PE, et al. Dermatol Online J. 2003 Oct;9(4):37. Dermatol Online J. 2003. PMID: 14594610 Free article.
Methionine epimerization in cyclic peptides.
Jadhav PD, Shen J, Burnett PG, Yang J, Sammynaiken R, Reaney MJT. Jadhav PD, et al. Among authors: burnett pg. RSC Adv. 2021 Jun 11;11(34):20859-20864. doi: 10.1039/d1ra04260b. eCollection 2021 Jun 9. RSC Adv. 2021. PMID: 35479339 Free PMC article.
Glycine-containing flaxseed orbitides.
Burnett PG, Jadhav PD, Okinyo-Owiti DP, Poth AG, Reaney MJ. Burnett PG, et al. J Nat Prod. 2015 Apr 24;78(4):681-8. doi: 10.1021/np5008558. Epub 2015 Mar 17. J Nat Prod. 2015. PMID: 25781981
165 results